10K out! BOOM we had sales in 2015! Get this.. Since

New Post Public Reply Private Reply Replies (1) Message Board
joey68
10K out! BOOM we had sales in 2015!

Get this..

Since 2012 Spectrascience sold $707,000 worth of consoles to PENTAX.

Lets do the math:

Between June 2012 and today, there were 1398 days.

SCIE sold $707,000 worth of product within that time period.

That comes out to be $505 EVERY day, including weekends, for 1,398 days straight. Sure its spread out, but that's less than 4 years! It's only 3 years and 9 months! And this was spread out because they were still doing trials and setting up the final stages for distribution.

Think about it.. the $707,000 worth of product sold is out there; somewhere. It's being used. And once sales really start to rev up, SCIE will probably be bringing in $707,000 or more a year.

For 2015, SCIE had $6,600 in sales!

Wait, is $6,600 in sales not enough for you? What's better? $0 in sales or $6,600. WHOO HOO!
It's a start! and hey, remember, no one is forcing anyone to stay invested.

NONE of the 62 holders of convertible debentures served notice! THIS IS UNHEARD OF! These 62 people know SCIE will be worth much more and are waiting to cash in on bigger profits.

Get this..as of March 29, 2016 there are 800 shareholders of record. That's great because the last 10K also had around 800 shareholders. This means long term investors are still holding strong and are not selling.

667 million outstanding shares. That's a great number! I know countless OTC stocks with no product in the BILLIONS of shares. This is a perfect number for SCIE to work with in this upcoming year.

All of the $6,600 sales were from PENTAX which means PENTAX is working on selling the product in Europe. Now that we are in 2016, things are going to slowly begin to move forward.

and guess what we get to look forward to in May? The 10Q! Yet another filing! And more than likely we'll get yet another PR in April and/or May! Even more information which will help boost the PPS.

So, its obvious SCIE is at the end of the trials period, yet is still in the trials period. This is ok in my book because the last thing I want is to have the WavSTAT4 sold around the world only to have the product recalled because it failed. So.. do all the trials they want! Get it right the first time!

Some of the best points:
the 10K says LUMA was acquired in 2007
Scrolling down to Patents section, it says the LUMA patents had an average life of 16 years. This means SCIE still has SIX YEARS left of owning the patents to this technology!! THIS IS HUGE! we have SIX YEARS left to work with before anyone can copy SCIE's tech. meaning? Possibility of an acquisition, buyout, or simply own the tech and rule the market.

SCIE has 30 WavSTATs ready to role out to Germany and the UK. More sales to come.

I cant wait to read hotstocked.com's review of how horrendous SCIE's 10K is. Whenever I need a good laugh I read their site.

Depreciation expense is good. Lower than 2014.

Although everyone has the right to complain, in my opinion, only comments from those who read the 10K in its entirety hold water. SCIE did exactly what they said they would do. They had sales in 2015. The company is still doing trials, they have convertible debentures, but the holders aren't cashing in.

Let me reiterate:
Did you see the part how SCIE sold $707,000 worth of consoles to PENTAX since 2012. This means there is an initial demand for the tech.

In all, I believe SCIE is a company meant for serious long term investors and will greatly reward those with the patience and the fortitude to wait. For right now, I look forward to short term investors selling their shares and looking for another stock which will make them a 'million dollars' in 6 days or less. These sold shares will end up in stronger hands and, as the company continues to grow, these shares will be worth a lot more. All in good time fellow longs!

GO SCIE!

SpectraSCIENCE Inc. (SCIE) Stock Research Links

SCIE Board Company Profile Buy Rating Time & Sales News Filings Financials
View My Board Here:
http://investorshangout.com/Joeys-Investment-Board-91611/


Invite Only

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.

Disclaimer:
As used herein, the terms "You" and "Your" shall mean you, individually, the reader, and each other party on whose behalf you may use the contained information at any time.
All references to "My", "I", and “The writer of the above post” shall refer to the creator of the username Joey68.

Do NOT invest unless you are prepared to sustain a total loss of the money you have invested plus any commission or other transaction charges.

There is a very high degree of risk involved in trading and investing. Past results are not indicative of future returns. I assume no responsibility for your trading and investment results. You should NOT rely on the information in the above post to make any decision or take any action.

ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are OPINION and NOT fact and are for entertainment purposes only. Do your own research and make your own decisions based on your own conclusions.
ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are NOT advice, and are NOT designed to substitute the expertise and judgment of a professional. It is your responsibility to seek investment advice during all stages of your investments. It is your responsibility to evaluate the accuracy, completeness and usefulness of the information in the above post.
I am NOT a professional.
I do NOT work for you.
My posts are NOT investment advice. I am not paid to post.
There is no correlation between the number of posts I write per day and your assumed success of a company.
It is NOT my responsibility to inform you of my own personal investment decisions.
It is NOT my responsibility to inform you when it is time for you to buy, hold, and/or sell a position.
I have no control over, and am not responsible for the actions of others who copy, store, edit, change, prepare any derivative work of or alter in any way any of the content provided in my posts.
Errors and Omissions expected. The writer of the above post accepts no liability or responsibility for any errors or omissions contained in the above post or contained within this Disclaimer.
The writer of the above post shall NOT accept any liability for the accuracy or completeness of the information contained in the above post, for any reliance placed by any person on the information contained in the above post, or for any damage or loss, however caused, in connection with the use or reliance on any information contained in the above post.
The above post may contain links to websites owned and operated by third parties. These links are provided for informational purposes only and are NOT endorsed by the writer of the above post. The writer of the above post has no control over the contents of any linked website and bears no responsibility for the accuracy, legality, or content of the external site or for that of subsequent links.
YOU ACCESS ALL LINKS ENTIRELY AT YOUR OWN RISK.
The writer of the above post makes no warranties or representations, express or implied about such linked websites, the third parties they are owned and operated by, or the information contained on these websites.
The writer of the above post accepts no liability for any damage or loss, however caused, in connection with the use of or reliance on any information, material, products, or services contained on or accessed through any such linked websites.

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Rural AI Skills Gap Uncovered: Challenges and Solutions

Updated Category News Views 86

Rural Workers Face Distinct AI Challenges Ah, life in the countryside might sound serene, but when it comes to keeping up with AI, rural folks aren't sipping lemonade and waiting on a windfall. The newly unveiled paper from the University of Phoenix College of Doctoral Studies shines a floodlight on some hefty challenges facing rural communities—particularly around...

Continue Reading
Chemours Class Action: Key Deadline Approaches Fast

Updated Category News Views 77

A Rocky Ride for Chemours Investors The ticker might read NYSE:CC, but right now, that might as well stand for "Caution, Cautious," if you ask me. Investors are on high alert with Chemours facing a class action lawsuit, and the stakes couldn’t be higher. Deadline's looming on December 7, 2026, for those gunning for lead plaintiff status. It's a tense time for anyone who...

Continue Reading
Langford Chosen for Navy Mutual's 2026 Bolles Award

Updated Category News Views 225

Awarding a Military Financial Educator There's something profoundly rewarding when hard work and dedication get their due recognition. That's precisely what's happened for Lacey Langford, who’s just been awarded the Lieutenant Timothy Dix Bolles Excellency in Education Award by the Navy Mutual Aid Association, or simply Navy Mutual. This isn’t just some...

Continue Reading
Millrose Properties Faces Legal Storm: Investors Alerted

Updated Category News Views 187

Millrose Properties: A Storm's Brewing Whoa, step back and take a wide-eyed look at Millrose Properties—there’s a storm brewin’ and it’s a doozy! Right now, they’re up against one mighty class action lawsuit, and investors who’ve been hit for over $100k better circle December 8, 2026, on their calendars if they fancy a shot at lead plaintiff glory. We’re...

Continue Reading
SCANOLOGY's AirGO Pad Revolutionizes On-Site Inspections

Updated Category News Views 157

Mobile 3D Scanning — Finally, Some Real Innovation Gone are the days where engineers had to cart around bulky laptops just to finish a simple inspection. SCANOLOGY has thrown a real game-changer into the mix with their new AirGO Pad. It's essentially a slick tablet that keeps your scanning, inspecting, and reporting all in one place, right beside whatever tangled hunk...

Continue Reading
Fashion and Philanthropy Unite at UBCF Kick-off Party

Updated Category News Views 65

Exclusivity and Dedication Mix at UBCF Event When fashion and philanthropy get together, you better believe it's more than just a pleasant evening. The Frederick Anderson Collection is hosting a swanky cocktail reception, kicking off the United Breast Cancer Foundation's (UBCF) highly-anticipated Think Pink Gala, and it's shaping up to be a unique affair wrapped in...

Continue Reading
Fluence Energy Faces Class Action: Investors Beware

Updated Category News Views 116

Storm Clouds Over Fluence Energy I'll tell you, I ain't surprised when companies face the music for dressing up their books. Fluence Energy, Inc. (NASDAQ: FLNC)—those wallopers are now caught in a legal maelstrom with a securities fraud class action lawsuit hanging over their heads. It's hard to feel sorry for 'em when the writing's on the wall. Allegations and...

Continue Reading
UBCF Strikes Big in Times Square with New Billboards

Updated Category News Views 113

From the Shadows to the Spotlight Ever seen someone step up to the plate and knock it out of the park? That's what the United Breast Cancer Foundation (UBCF) is doing by plastering their mission right across Times Square. Talk about grabbing the bull by the horns, eh? With not one, but two billboards now gracing one of the globe's most iconic public spaces, they've...

Continue Reading
HanAll F&B Pioneers New Path for Domestic Rice Noodles

Updated Category News Views 173

New Spin on an Old Favorite: Rice Noodles Forget about the same old wheat noodles clogging up the pantry. HanAll F&B is revamping the noodle game with a homegrown twist, setting sights on a future where Korean rice isn't just for steaming, soup, or sushi. This outfit from Taebaek, Gangwon, has got its hands deep in the rice flour, finessing a patent that aims to make...

Continue Reading
Zhimeng Biopharma Hits Key Milestone in ALS Drug Trial

Updated Category News Views 156

Pivotal Point for Zhimeng's ALS Efforts Folks, get this—Zhimeng Biopharma's rolling out the big guns here with a significant step forward in their ALS treatment quest. This company just wrapped up patient enrollment for their next-gen ALS drug, CB03-154. We're talking about 255 patients now on board for a Phase 2/3 trial. The ground's shaking a bit because this...

Continue Reading

Top 5 Most Recently Viewed Articles

EarthCam Unveils Revolutionary AI Camera for Construction Safety

Updated Category News Views 302

EarthCam Launches AI-Powered Mobile StreamCam Robotic EarthCam, a leader in visual technology, has unveiled its new Mobile StreamCam Robotic aimed at enhancing monitoring capabilities in interior construction. This innovative camera is designed to combine advanced live-streaming features with smart AI insights, providing construction teams with real-time data and...

Continue Reading
Investors Should Act Now: iLearningEngines Class Action News

Updated Category News Views 140

Understanding the iLearningEngines Class Action Lawsuit The well-regarded law firm Faruqi & Faruqi, LLP is currently inviting investors of iLearningEngines, Inc. to stay informed about an important class action lawsuit. This lawsuit revolves around allegations that iLearningEngines engaged in misleading practices fundamentally impacting its investors. The deadline to seek...

Continue Reading
Sarepta's Gene Therapy Under Investigation Following Tragic Death

Updated Category News Views 130

Investigation into Elevidys Following a Tragic Incident The U.S. Food and Drug Administration (FDA) has begun an investigation into the unfortunate death of a young boy who was administered Elevidys, Sarepta Therapeutics Inc.’s gene therapy designed for treating Duchenne muscular dystrophy. This announcement came after market close, raising concerns regarding the safety...

Continue Reading
2Rivers Group Enhances Market Position in West Africa

Updated Category News Views 56

2Rivers Group Expands Operations into West Africa 2Rivers Group is excited to announce its ongoing expansion into the West African market, reinforcing its status as a key entity in the global energy trading and distribution landscape. This initiative aligns perfectly with the company’s vision of achieving sustainable growth in important markets around the world....

Continue Reading
Pathward Financial Announces Upcoming Q1 2025 Earnings Call

Updated Category News Views 189

Pathward Financial to Announce Earnings for First Quarter 2025 Pathward Financial, Inc. has made an important announcement regarding its upcoming financial results for the first quarter of fiscal year 2025. The release is set for Tuesday, after the market closes, and the company is eager to share insights from these results. Conference Call Scheduled A conference call and...

Continue Reading